Lisata Therapeutics, based in Basking Ridge, New Jersey, focuses on developing therapies for advanced solid tumors, with its lead candidate LSTA1 enhancing anti-cancer drug penetration in tumors. The company also explores CD34+ cell therapy for various diseases, including critical limb ischemia and diabetic kidney disease.
LSTA has been in the news recently: LISATA THERAPEUTICS is not directly mentioned in the provided information, but several relevant entities, such as Nona Biosciences and March Biosciences, are advancing innovative cancer treatments and therapies. Notably, March Biosciences received funding to improve CAR-T cell therapy manufacturing, while Nona Biosciences showcased promising preclinical data on a novel cancer drug at a recent conference.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
